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Abstract 
Introduction: Since the end of 2014, Zika virus (ZIKV) infection has been rapidly spreading in Brazil.  
Methodology: To analyze the possible association of yellow fever vaccine with a protective effect against ZIKV-related microcephaly, the 
following spatial analyses were performed, using Brazilian municipalities as units: i) yellow fever vaccination coverage in Brazilian 
municipalities in individuals aged 15-49; ii) reported cases of microcephaly by municipality; and iii) confirmed cases of microcephaly related 
to ZIKV, by municipality. SaTScan software was used to identify clusters of municipalities for high risk of microcephaly. 
Results: There were seven significant high risk clusters of confirmed microcephaly cases, with four of them located in the Northeast where 
yellow fever vaccination rates were the lowest. The clusters harbored only 2.9% of the total population of Brazil, but 15.2% of confirmed cases 
of microcephaly. 
Conclusion: We hypothesize that pregnant women in regions with high yellow fever vaccination coverage may pose their offspring to lower 
risk for development of microcephaly. There is an urgent need for systematic studies to confirm the possible link between low yellow fever 
vaccination coverage, Zika virus infection and microcephaly. 
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Introduction 
Since the end of 2014, Zika virus (ZIKV) infection 
has been rapidly spreading in Brazil, especially in the 
Northeast region of the country [1-4]. In June 2015, the 
Brazilian Ministry of Health (MoH) identified the first 
cases of neurological syndromes in patients with a 
history of exanthematic disease in endemic regions for 
arboviruses (ZIKV, DENV and Chikungunya virus) 
[5,6], and since September 2015 the number of notified 
cases of microcephaly has increased steadily [2]. As a 
consequence, MoH instructed the Federal States to 
report all cases of neurological syndromes and 
microcephaly [7]. By March 2016, a total of 6,381 
suspected microcephaly cases were reported, and 854 
confirmed; many of them occurred in infants born to 
women living in areas of ZIKV transmission. 
Transmission of ZIKV was confirmed in 22 of Brazil’s 
26 states including the Federal District.  
ZIKV and yellow fever virus, in its urban 
transmission cycle, both share the same mosquito 
vector, Aedes mosquitoes. Yellow fever is an acute 
vector-borne short term viral disease. Despite the 
availability of an effective vaccine, there is still active 
transmission in many countries [8]. In Brazil, 
autochthonous cases of sylvatic yellow fever regularly 
occur in small clusters, transmitted by other mosquito 
species. In 2015, 7 autochthonous cases of yellow fever 
were reported [9]. Consequently, yellow fever 
vaccination is recommended for residents and for 
travelers directed to 18 of the 27 Federal States [10]. In 
the 9 remaining States, mostly located on the coastline 
along the Atlantic Ocean, transmission risk is 
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considered very low to negligible, and vaccination of 
the general population is not recommended [11]. 
However, there is no consensus on expanding 
vaccination to the entire country [12].  
Considering the close relation of other arboviruses 
with ZIKV, such as the yellow fever virus, it might be 
speculated that yellow fever vaccine to some extent 
may provide a protective effect against severe disease 
and sequelae caused by ZIKV infection, such as 
microcephaly. 
 
Methods 
Brazil is a country of continental dimensions, with 
a population of approximately 205 million inhabitants 
and 5,570 municipalities, with major parts of its 
territory considered as risk areas for yellow fever 
transmission. 
Three different descriptive spatial analyses were 
performed, using the Brazilian municipalities as units 
of analysis: 1. yellow fever vaccination coverage in 
Brazilian municipalities in individuals aged 15-49 
years; 2. reported cases of microcephaly by 
municipality; and 3. confirmed cases of microcephaly 
related to ZIKV, by municipality. 
Spatial scan statistic analysis was performed, using 
SaTScan software package version 9.4.2 (Harvard 
Medical School, Boston, USA), to identify significant 
clusters of Brazilian municipalities for high risk of 
Figure 1. (A) Yellow fever vaccination coverage in individuals aged 15-49 in Brazil; (B) reported cases of microcephaly between October 
2015 and March 2016; (C) confirmed cases of microcephaly between October 2015 and March 2016; (D) clusters of confirmed cases of 
microcephaly associated with ZIKV; arrows indicate location of clusters. Observation units are the 5,570 municipalities of Brazil.  
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microcephaly. SaTScan uses a flexible geographic 
scanning window and includes different sets of 
neighboring areas. These clusters were identified using 
pure spatial analysis with a radius assuming 50% of the 
population at risk. Vaccination coverage data by 
municipality are freely available and were obtained 
from the Informatics Department of the Unified Health 
System - DATASUS (http://tabnet.datasus.gov.br). 
Notified and confirmed cases of microcephaly were 
provided by the Brazilian MoH. 
 
Results 
Data showed that in the Northeast of the country - 
the region most heavily affected by Zika-related 
microcephaly – yellow fever vaccination coverage was 
the lowest (Figure 1A-C). We identified seven 
significant clusters at high risk for confirmed 
microcephaly cases, consisting of three or more 
municipalities (Figure 1D). Four out of these clusters 
were located in the Northeast of the country. The most 
extensive cluster consisted of 176 municipalities in 
Pernambuco (PE), Paraíba (PB) and Rio Grande do 
Norte (RN) states (Figure 1D), followed by another 
major cluster consisting of 110 municipalities in Bahia 
State (BA). There was also another isolated small 
cluster in Bahia State. An additional cluster in the 
northeast of the country includes Rio Grande do Norte 
(RN) and Paraíba (PB) States (59 municipalities). The 
remaining three clusters were smaller and located in 
other areas of the country, namely in Minas Gerais 
(MG) and São Paulo (SP) States. All clusters harbored 
only 2.9% of the total population of Brazil, but 15.2% 
of confirmed cases of microcephaly (p < 0.001). During 
the last 15 years, all 333 yellow fever cases occurred in 
areas where yellow fever vaccination is recommended. 
 
Conclusion 
Our analysis indicates that pregnant women in 
regions with high yellow fever vaccination coverage 
may pose their offspring to lower risk to develop 
microcephaly. 
In fact, vaccination against Japanese encephalitis, 
dengue fever and yellow fever may produce cross-
reactive antibodies. Antibody cross-reactivity is known 
to occur between different flavivírus infections, such as 
yellow fever, Japanese encephalitis, and dengue fever 
[13,14], and in a historical study, a volunteer infected 
with ZIKV virus produced antibodies against both 
yellow fever virus and ZIKV [15]. 
We are aware that this is a small descriptive study, 
and that our ecological data are prone to confounders 
and bias (such as environmental factors that may 
influence the spread of Zika virus in yellow fever-
endemic areas). Therefore, no causal relationship can 
be established, and we emphasize an urgent need for 
systematic studies to confirm the possible link between 
low yellow fever vaccine coverage and microcephaly. 
Our data also suggest that a vaccine based on the 
existing yellow fever vaccine should be considered. 
Additional systematic studies are needed, such as a 
cohort study investigating yellow fever antibody titres 
in populations at risk. Adequately designed laboratory-
based investigations and studies on animals need to be 
performed to investigate the possible protective effect 
of yellow fever vaccination against subsequent 
infection with Zika virus, and thus microcephaly. 
 
 
References 
1. Cao-Lormeau VM, Roche C, Teissier A, Robin E, Berry AL, 
Mallet HP, Sall AA, Musso D (2014) Zika virus, French 
polynesia, South pacific, 2013. Emerg Infect Dis. 2014 
20:1085-1086. doi: 10.3201/eid2006.140138 PubMed PMID: 
24856001. Pubmed Central PMCID: PMC4036769. 
2. Heukelbach J, Alencar CH, Kelvin AA, De Oliveira WK, 
Pamplona de Goes Cavalcanti L (2016) Zika virus outbreak in 
Brazil. J Infect Dev Ctries. 10:116-120. PubMed PMID: 
26927450. 
3. Kleber de Oliveira W, Cortez-Escalante J, De Oliveira WT, do 
Carmo GM, Henriques CM, Coelho GE, Araújo de França GV 
(2016) Increase in reported prevalence of microcephaly in 
infants born to women living in areas with confirmed Zika 
Virus transmission during the first trimester of pregnancy - 
Brazil, 2015. MMWR Morb Mortal Wkly Rep.  doi: 
10.15585/mmwr.mm6509e2. 65:242-247. PubMed PMID: 
26963593.  
4. Zanluca C, Melo VC, Mosimann AL, Santos GI, Santos CN, 
Luz K (2015) First report of autochthonous transmission of 
Zika virus in Brazil. Mem Inst Oswaldo Cruz. 110:569-572. 
PubMed PMID: 26061233. Pubmed Central PMCID: 
PMC4501423. 
5. Ventura CV, Maia M, Bravo-Filho V, Gois AL, Belfort R, Jr 
(2016) Zika virus in Brazil and macular atrophy in a child with 
microcephaly. Lancet. 387:228. PubMed PMID: 26775125. 
6. Oliveira Melo AS, Malinger G, Ximenes R, Szejnfeld PO, 
Alves Sampaio S, Bispo de Filippis AM (2016) Zika virus 
intrauterine infection causes fetal brain abnormality and 
microcephaly: tip of the iceberg? Ultrasound Obstet Gynecol. 
47:6-7. PubMed PMID: 26731034. 
7. Brasil. Protocolo de vigilância e resposta à ocorrência de 
microcefalia. Brasilia: Ministério da Saúde - Secretaria de 
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